Jonathan Boone, MD
Gynecologic Oncology · Knoxville, TNNPI 1235457151
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations.
Across 181 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$992
- AstraZeneca$479
- GSK$403
- Intuitive Surgical$364
- AbbVie$314
- Eisai Inc.$276
- plus $1K from 23 others
Across 23 payments — averaging $8425.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$161K
- Karyopharm Therapeutics Inc.$33K
What the payments were for
- Food & beverage$4,06497%
- Education$1403%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 45 | $992 |
| AstraZeneca | 23 | $479 |
| GSK | 21 | $403 |
| Intuitive Surgical | 7 | $364 |
| AbbVie | 14 | $314 |
| Eisai Inc. | 13 | $276 |
| Davol Inc. | 2 | $158 |
| Clovis Oncology, Inc. | 6 | $121 |
| Immunogen, Inc. | 5 | $113 |
| Tempus AI, Inc | 4 | $107 |
| Daiichi Sankyo Inc. | 4 | $102 |
| Seagen Inc. | 5 | $93 |
| Pfizer | 5 | $88 |
| Johnson & Johnson | 3 | $83 |
| Tactile Systems Technology Inc | 2 | $73 |
| Astellas Pharma US Inc | 2 | $57 |
| Caris MPI, Inc. | 2 | $49 |
| Bayer | 3 | $48 |
| Foundation Medicine, Inc. | 3 | $44 |
| Conmed Corporation | 2 | $40 |
| Tesaro, Inc. | 1 | $35 |
| Myriad Genetic Laboratories, Inc. | 2 | $31 |
| Baxter Healthcare | 1 | $25 |
| Biom'up France SAS | 1 | $23 |
| Boston Scientific | 1 | $20 |
| Spectrum Pharmaceuticals Inc. | 1 | $19 |
| Novartis | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Coherus Oncology, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROGEL$142
- Da Vinci Surgical System$140
How this compares
$4,204 in reported general payments places this provider in the 55th percentile of 40 gynecologic oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Knoxville
- Larry KilgoreKnoxville$7K
- Kristopher KimballKnoxville$4K
- David MartinKnoxville$1K
- Brook SaundersKnoxville$892
- Kenneth CoferKnoxville$390
- Don HallKnoxville$30
- Todd TillmannsGermantown$127K
- Ronald AlvarezNashville$33K
- Adam ElnaggarGermantown$29K
- Michael StanyNashville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.